阿尔茨海默病血浆诊断标志物研究进展

被引：6

作者：

孙亮

陈彪

机构：

[1] 首都医科大学宣武医院

来源：

中国实用内科杂志 | 2012年 / 32卷 / 05期

关键词：

阿尔茨海默病; 血浆标志物; 认知功能损害;

D O I：

暂无

中图分类号：

R749.16 [];

学科分类号：

100203 ;

摘要：

<正>阿尔茨海默病(AD)是隐袭起病的神经系统变性病,在出现临床症状,甚至仅表现为轻度认知功能损害(MCI)时已经存在广泛而严重的神经系统病理改变,错过了有效预防和早期干预的时机。因此,寻找AD亚临床阶段的诊断标志物具有重要意义。按

引用

页码：383 / 385

页数：3

共 5 条

[1] Plasma biomarkers for mild cognitive impairment and Alzheimer's disease [J].

Song, Fei ;

Poljak, Anne ;

Smythe, George A. ;

Sachdev, Perminder .

BRAIN RESEARCH REVIEWS, 2009, 61 (02) :69-80

[2]

Inflammatory markers in AD and MCI patients with different biomarker profiles[J] . Alie Schuitemaker,Miranda G. Dik,Robert Veerhuis,Philip Scheltens,Niki S.M. Schoonenboom,C. Erik Hack,Marinus A. Blankenstein,Cees Jonker. Neurobiology of Aging . 2008 (11)

[3]

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study[J] . O L. Lopez,L H. Kuller,P D. Mehta,J T. Becker,H M. Gach,R A. Sweet,Y F. Chang,R Tracy,S T. DeKosky. Neurology . 2008 (19,)

[4] Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment [J].

Reitz, Christiane ;

Tang, Ming-Xin ;

Manly, Jennifer ;

Schupf, Nicole ;

Mayeux, Richard ;

Luchsinger, Jose A. .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (03) :232-237

[5] Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease [J].

Liao, Pao-Chi ;

Yu, Lung ;

Kuo, Chih-Chieh ;

Lin, Chingju ;

Kuo, Yu-Min .

PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (05) :506-512

← 1 →